Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Table of Contents

July 2019; Volume 39,Issue 7

Special Issue on New Anticancer Agents

Reviews

  • You have access
    A Systematic Review and Meta-analysis of the Combination of Vinorelbine and Lapatinib in Patients With Her2-positive Metastatic Breast Cancer
    ATHINA STRAVODIMOU and IOANNIS A. VOUTSADAKIS
    Anticancer Research July 2019, 39 (7) 3295-3301; DOI: https://doi.org/10.21873/anticanres.13471
  • You have access
    To Combine or Not Combine: Drug Interactions and Tools for Their Analysis. Reflections from the EORTC-PAMM Course on Preclinical and Early-phase Clinical Pharmacology
    BTISSAME EL HASSOUNI, GIULIA MANTINI, GIOVANNA LI PETRI, MJRIAM CAPULA, LENKA BOYD, HANNAH N.W. WEINSTEIN, ANDREA VALLÉS-MARTI, MATHILDE C.M. KOUWENHOVEN, ELISA GIOVANNETTI, BART A. WESTERMAN, GODEFRIDUS J. PETERS and on Behalf of the EORTC PAMM Group
    Anticancer Research July 2019, 39 (7) 3303-3309; DOI: https://doi.org/10.21873/anticanres.13472
  • You have access
    The Role of PEDF in Pancreatic Cancer
    DANIEL ANSARI, CARL ALTHINI, HENRIK OHLSSON, MONIKA BAUDEN and ROLAND ANDERSSON
    Anticancer Research July 2019, 39 (7) 3311-3315; DOI: https://doi.org/10.21873/anticanres.13473
  • You have access
    The Hippo Signaling Pathway in Pancreatic Cancer
    DANIEL ANSARI, HENRIK OHLSSON, CARL ALTHINI, MONIKA BAUDEN, QIMIN ZHOU, DINGYUAN HU and ROLAND ANDERSSON
    Anticancer Research July 2019, 39 (7) 3317-3321; DOI: https://doi.org/10.21873/anticanres.13474
  • You have access
    Drug Delivery Systems for Phthalocyanines for Photodynamic Therapy
    JAKUB RAK, PAVLA POUCKOVA, JIRI BENES and DAVID VETVICKA
    Anticancer Research July 2019, 39 (7) 3323-3339; DOI: https://doi.org/10.21873/anticanres.13475
  • You have access
    From ‘Targeted Therapy’ to Targeted Therapy
    GODEFRIDUS J. PETERS
    Anticancer Research July 2019, 39 (7) 3341-3345; DOI: https://doi.org/10.21873/anticanres.13476
  • You have access
    Regulation of BS69 Expression in Cancers
    YUN CHEN, YA-HUI TSAI and SHENG-HONG TSENG
    Anticancer Research July 2019, 39 (7) 3347-3351; DOI: https://doi.org/10.21873/anticanres.13477
  • You have access
    Potential Molecular Mechanisms of the Anti-cancer Activity of Vitamin D
    DOROTA SKRAJNOWSKA and BARBARA BOBROWSKA-KORCZAK
    Anticancer Research July 2019, 39 (7) 3353-3363; DOI: https://doi.org/10.21873/anticanres.13478
  • You have access
    Therapy Aimed to Suppress the Production of the Immunosuppressive Protein Progesterone Induced Blocking Factor (PIBF) May Provide Palliation and/or Increased Longevity for Patients With a Variety of Different Advanced Cancers – A Review
    JEROME H. CHECK and DIANE CHECK
    Anticancer Research July 2019, 39 (7) 3365-3372; DOI: https://doi.org/10.21873/anticanres.13479
  • You have access
    Glucans as New Anticancer Agents
    PETR SIMA, JOSEF RICHTER and VACLAV VETVICKA
    Anticancer Research July 2019, 39 (7) 3373-3378; DOI: https://doi.org/10.21873/anticanres.13480
  • You have access
    Inhibitors of Protein Tyrosine Phosphatase PTP1B With Anticancer Potential
    TOMASZ KOSTRZEWA, JOANNA STYSZKO, MAGDALENA GORSKA-PONIKOWSKA, TOMASZ SLEDZINSKI and ALICJA KUBAN-JANKOWSKA
    Anticancer Research July 2019, 39 (7) 3379-3384; DOI: https://doi.org/10.21873/anticanres.13481
  • You have access
    Acyl-Coenzyme A: Cholesterol Acyltransferase Inhibition in Cancer Treatment
    JUDYTA ZABIELSKA, TOMASZ SLEDZINSKI and EWA STELMANSKA
    Anticancer Research July 2019, 39 (7) 3385-3394; DOI: https://doi.org/10.21873/anticanres.13482
  • You have access
    Extracellular Vesicles: Subcellular Organelles With the Potential to Spread Cancer Resistance
    FANNY ENDER, NIKOLAS VON BUBNOFF and FRANK GIESELER
    Anticancer Research July 2019, 39 (7) 3395-3404; DOI: https://doi.org/10.21873/anticanres.13483
  • You have access
    State of the Art for Metastatic Pancreatic Cancer Treatment: Where Are We Now?
    RITA BALSANO, CHIARA TOMMASI and INGRID GARAJOVA
    Anticancer Research July 2019, 39 (7) 3405-3412; DOI: https://doi.org/10.21873/anticanres.13484
  • You have access
    A Brief Guide to Performing Pharmacological Studies In Vitro: Reflections from the EORTC-PAMM Course “Preclinical and Early-phase Clinical Pharmacology”
    MJRIAM CAPULA, CRISTINA CORNO, BTISSAME EL HASSOUNI, GIOVANNA LI PETRI, SANDRA ARANĐELOVIĆ and on Behalf of the EORTC PAMM Group
    Anticancer Research July 2019, 39 (7) 3413-3418; DOI: https://doi.org/10.21873/anticanres.13485
  • You have access
    Is There Any Room for Pharmacometrics With Immuno-Oncology Drugs? Input from the EORTC-PAMM Course on Preclinical and Early-phase Clinical Pharmacology
    ANNE RODALLEC, RAPHAELLE FANCIULLINO, SEBASTIEN BENZEKRY, JOSEPH CICCOLINI and on Behalf of the EORTC PAMM Group
    Anticancer Research July 2019, 39 (7) 3419-3422; DOI: https://doi.org/10.21873/anticanres.13486
  • You have access
    Pleiotropic Chemotherapy to Abrogate Glioblastoma Multiforme Migration/Invasion
    LAWRENCE HELSON and MUHAMMED MAJEED
    Anticancer Research July 2019, 39 (7) 3423-3427; DOI: https://doi.org/10.21873/anticanres.13487
  • You have access
    In Vitro Anticancer Activities of B6 Vitamers: A Mini-review
    TAISUKE MATSUO and YASUYUKI SADZUKA
    Anticancer Research July 2019, 39 (7) 3429-3432; DOI: https://doi.org/10.21873/anticanres.13488

Experimental Studies

  • You have access
    Biochemical Inhibition of DOG1/TMEM16A Achieves Antitumoral Effects in Human Gastrointestinal Stromal Tumor Cells In Vitro
    ROBIN FRÖBOM, FELIX SELLBERG, CHENG XU, ALLAN ZHAO, CATHARINA LARSSON, WENN-ONN LUI, INGA-LENA NILSSON, ERIK BERGLUND and ROBERT BRÄNSTRÖM
    Anticancer Research July 2019, 39 (7) 3433-3442; DOI: https://doi.org/10.21873/anticanres.13489
  • You have access
    Oxidative DNA Damage and Apoptosis Induced by Aclarubicin, an Anthracycline: Role of Hydrogen Peroxide and Copper
    HIDEKI MIZUTANI, YUKA HAYASHI, MIYABI HASHIMOTO, MASANORI IMAI, YOSHIMI ICHIMARU, YUKI KITAMURA, KENJI IKEMURA, DAISUKE MIYAZAWA, KINYA OHTA, YOSHIAKI IKEDA, TOHRU MAEDA, MASAE YOSHIKAWA, YUSUKE HIRAKU and SHOSUKE KAWANISHI
    Anticancer Research July 2019, 39 (7) 3443-3451; DOI: https://doi.org/10.21873/anticanres.13490
  • You have access
    Unravelling the Antiproliferative Activity of 1,2,5-oxadiazole Derivatives
    DANIEL EHRSAM, FABIOLA PORTA, MATTEO MORI, HENRIETTE E. MEYER ZU SCHWABEDISSEN, LISA DALLA VIA, AÌDA NELLY GARCIA-ARGAEZ, LIVIA BASILE, FIORELLA MENEGHETTI, STEFANIA VILLA and ARIANNA GELAIN
    Anticancer Research July 2019, 39 (7) 3453-3461; DOI: https://doi.org/10.21873/anticanres.13491
  • You have access
    Peritoneal Metastases in a Patient-derived Orthotopic Xenograft (PDOX) Model of Colon Cancer Imaged Non-invasively via Red Fluorescent Protein Labeled Stromal Cells
    JUN HO PARK, MING ZHAO, HIROMICHI OSHIRO, KENTARO MIYAKE, TAKASHI HIGUCHI, JOSE REYNOSO, SAHAR RAZMJOOEI, MICHAEL BOUVET, BRYAN CLARY, ZHIYING ZHANG, NORIHIKO SUGISAWA, JUN YAMAMOTO, SHREE RAM SINGH and ROBERT M. HOFFMAN
    Anticancer Research July 2019, 39 (7) 3463-3467; DOI: https://doi.org/10.21873/anticanres.13492
  • You have access
    Natural and Synthetic Isothiocyanates Possess Anticancer Potential Against Liver and Prostate Cancer In Vitro
    EMILY CROWLEY, NEIL J. ROWAN, DON FALLER and ANNE M. FRIEL
    Anticancer Research July 2019, 39 (7) 3469-3485; DOI: https://doi.org/10.21873/anticanres.13493
  • You have access
    Acyclic Retinoid Combined With Tenascin-C-derived Peptide Reduces the Malignant Phenotype of Neuroblastoma Cells Through N-Myc Degradation
    KAZUKI OTSUKA, MANABU SASADA, YU HIRANO, YUSUKE NOHARA, TAKUYA IYODA, YOSHIKAZU HIGAMI, HIROAKI KODAMA and FUMIO FUKAI
    Anticancer Research July 2019, 39 (7) 3487-3492; DOI: https://doi.org/10.21873/anticanres.13494
  • You have access
    IL-29 Exhibits Anti-Tumor Effect on Pan-48 Pancreatic Cancer Cells by Up-regulation of P21 and Bax
    DEAN BALABANOV, LEI ZHAO, ZIWEN ZHU, ZACHARY E. HUNZEKER, HANNAH M. TONNER, VIVI A. DING, MARK R. WAKEFIELD, QIAN BAI and YUJIANG FANG
    Anticancer Research July 2019, 39 (7) 3493-3498; DOI: https://doi.org/10.21873/anticanres.13495
  • You have access
    Phenformin Induces Caspase-dependent Apoptosis of FaDu Head and Neck Squamous Cell Carcinoma Cells
    YO-SEOB SEO, TAE-HYEON KIM, HYANGI LIM, JI-SU OH, JAE-SEEK YOU, GYEONG-JE LEE, SUN-KYOUNG YU, DO KYUNG KIM, HEUNG-JOONG KIM, CHUN SUNG KIM, SOOK-YOUNG LEE, SU-GWAN KIM and JAE-SUNG KIM
    Anticancer Research July 2019, 39 (7) 3499-3506; DOI: https://doi.org/10.21873/anticanres.13496
  • You have access
    Quantitative Structure–Cytotoxicity Relationship of Azulene Amide Derivatives
    KANA IMANARI, MASASHI HASHIMOTO, HIDETSUGU WAKABAYASHI, NORIYUKI OKUDAIRA, KENJIRO BANDOW, JUNKO NAGAI, MINEKO TOMOMURA, AKITO TOMOMURA, YOSHIHIRO UESAWA and HIROSHI SAKAGAMI
    Anticancer Research July 2019, 39 (7) 3507-3518; DOI: https://doi.org/10.21873/anticanres.13497
  • You have access
    Induction of Non-Apoptotic Cell Death by Adrenergic Agonists in Human Oral Squamous Cell Carcinoma Cell Lines
    SHIGENORI UCHIDA, KATSUE KOBAYASHI, SEIKA OHNO, HIROSHI SAKAGAMI, HIKARU KOHASE and HIROSHI NAGASAKA
    Anticancer Research July 2019, 39 (7) 3519-3529; DOI: https://doi.org/10.21873/anticanres.13498
  • You have access
    Simultaneous Inhibition of Protein Kinase CK2 and Dihydrofolate Reductase Results in Synergistic Effect on Acute Lymphoblastic Leukemia Cells
    PATRYCJA WIŃSKA, ŁUKASZ WIDŁO, KATARZYNA SKIERKA, ALICJA KRZYŚKO, MIROSŁAWA KORONKIEWICZ, JAROSŁAW M. CIEŚLA, JOANNA CIEŚLA and MARIA BRETNER
    Anticancer Research July 2019, 39 (7) 3531-3542; DOI: https://doi.org/10.21873/anticanres.13499
  • You have access
    Bevacizumab Versus Anti-preeclamptic Drugs: Evaluation With Three-dimensionally Co-cultured Human Mini Tumors
    CHEN PAN, KENJI ONDA and TOSHIHIKO HIRANO
    Anticancer Research July 2019, 39 (7) 3543-3551; DOI: https://doi.org/10.21873/anticanres.13500
  • You have access
    Schlafen11 Expression Is Associated With the Antitumor Activity of Trabectedin in Human Sarcoma Cell Lines
    JUNYA IWASAKI, TOSHIHARU KOMORI, FUMIO NAKAGAWA, HIDEKI NAGASE, JUNJI UCHIDA, KENICHI MATSUO and YOSHIHIRO UTO
    Anticancer Research July 2019, 39 (7) 3553-3563; DOI: https://doi.org/10.21873/anticanres.13501
  • You have access
    ChIP-seq Analysis to Explore DNA Replication Profile in Trifluridine-treated Human Colorectal Cancer Cells In Vitro
    TAKASHI KOBUNAI, KAZUAKI MATSUOKA and TEIJI TAKECHI
    Anticancer Research July 2019, 39 (7) 3565-3570; DOI: https://doi.org/10.21873/anticanres.13502
  • You have access
    Down-regulation of Survivin by BIX-01294 Pretreatment Overcomes Resistance of Hepatocellular Carcinoma Cells to TRAIL
    YENA NAMGUNG, SO YOUNG KIM and INKI KIM
    Anticancer Research July 2019, 39 (7) 3571-3578; DOI: https://doi.org/10.21873/anticanres.13503
  • You have access
    Combined Inhibition of ALK and HDAC Induces Synergistic Cytotoxicity in Neuroblastoma Cell Lines
    KAZUMI HAGIWARA, TAKASHI TOKUNAGA, HIROATSU IIDA and HIROKAZU NAGAI
    Anticancer Research July 2019, 39 (7) 3579-3584; DOI: https://doi.org/10.21873/anticanres.13504
  • You have access
    Broad-spectrum Cross-resistance to Anticancer Drugs Mediated by Epidermal Growth Factor Receptor
    GE YAN and THOMAS EFFERTH
    Anticancer Research July 2019, 39 (7) 3585-3593; DOI: https://doi.org/10.21873/anticanres.13505
  • You have access
    Perampanel Inhibits Neuroblastoma Cell Proliferation Through Down-regulation of AKT and ERK Pathways
    AKIFUMI NOZAWA, MICHIO OZEKI, MIKAKO MATSUOKA, MINA NAKAMA, SHIHO YASUE, SAORI ENDO, NORIO KAWAMOTO, HIDENORI OHNISHI and TOSHIYUKI FUKAO
    Anticancer Research July 2019, 39 (7) 3595-3599; DOI: https://doi.org/10.21873/anticanres.13506
  • You have access
    The Involvement of Pregnane X Receptor-regulated Pathways in the Antitumor Activity of Cisplatin
    MEGUMI YASUDA, SHUICHI KISHIMOTO, MANABU AMANO and SHOJI FUKUSHIMA
    Anticancer Research July 2019, 39 (7) 3601-3608; DOI: https://doi.org/10.21873/anticanres.13507
  • You have access
    Uridine Cytidine Kinase 2 as a Potential Biomarker for Treatment with RX-3117 in Pancreatic Cancer
    BTISSAME EL HASSOUNI, JESSICA INFANTE, GIULIA MANTINI, CLAUDIO RICCI, NICCOLA FUNEL, ELISA GIOVANNETTI and GODEFRIDUS J. PETERS
    Anticancer Research July 2019, 39 (7) 3609-3614; DOI: https://doi.org/10.21873/anticanres.13508
  • You have access
    Biological Evaluation of the Antiproliferative and Anti-migratory Activity of a Series of 3-(6-Phenylimidazo[2,1-b][1,3,4]thiadiazol-2-yl)-1H-indole Derivatives Against Pancreatic Cancer Cells
    GIOVANNA LI PETRI, STELLA CASCIOFERRO, BTISSAME EL HASSOUNI, DANIELA CARBONE, BARBARA PARRINO, GIROLAMO CIRRINCIONE, GODEFRIDUS J. PETERS, PATRIZIA DIANA and ELISA GIOVANNETTI
    Anticancer Research July 2019, 39 (7) 3615-3620; DOI: https://doi.org/10.21873/anticanres.13509
  • You have access
    Cetrimonium Bromide Inhibits Cell Migration and Invasion of Human Hepatic SK-HEP-1 Cells Through Modulating the Canonical and Non-canonical TGF-β Signaling Pathways
    TSAI-KUN WU, CHUNG-HUNG CHEN, YING-RU PAN, CHING-WEN HU, FU-MEI HUANG, JER-YUH LIU and CHIA-JEN LEE
    Anticancer Research July 2019, 39 (7) 3621-3631; DOI: https://doi.org/10.21873/anticanres.13510
  • You have access
    DL-Methadone as an Enhancer of Chemotherapeutic Drugs in Head and Neck Cancer Cell Lines
    VERONIKA LANDGRAF, MATTHIAS GRIESSMANN, JEANETTE ROLLER, CHRISTINE POLEDNIK and MARIANNE SCHMIDT
    Anticancer Research July 2019, 39 (7) 3633-3639; DOI: https://doi.org/10.21873/anticanres.13511
  • You have access
    Amentoflavone Induces Apoptosis and Reduces Expression of Anti-apoptotic and Metastasis-associated Proteins in Bladder Cancer
    CHIH-HUNG CHIANG, CHING-YI YEH, JING GUNG CHUNG, I-TSANG CHIANG and FEI-TING HSU
    Anticancer Research July 2019, 39 (7) 3641-3649; DOI: https://doi.org/10.21873/anticanres.13512
  • You have access
    Inhibition of Pancreatic Carcinoma Growth Through Enhancing ω-3 Epoxy Polyunsaturated Fatty Acid Profile by Inhibition of Soluble Epoxide Hydrolase
    RONG XIA, LEYU SUN, JIE LIAO, HAONAN LI, XIAOMING YOU, DANDAN XU, JUN YANG, SUNG HEE HWANG, RYAN D. JONES, BRUCE HAMMOCK and GUANG-YU YANG
    Anticancer Research July 2019, 39 (7) 3651-3660; DOI: https://doi.org/10.21873/anticanres.13513
  • You have access
    Selective Wnt/β-catenin Small-molecule Inhibitor CWP232228 Impairs Tumor Growth of Colon Cancer
    JIN YOUNG KIM, GEUMI PARK, MANIGANDAN KRISHNAN, EUNYOUNG HA and KYUNG-SOO CHUN
    Anticancer Research July 2019, 39 (7) 3661-3667; DOI: https://doi.org/10.21873/anticanres.13514
  • You have access
    Suppression of ERK/NF-κB Activation Is Associated With Amentoflavone-Inhibited Osteosarcoma Progression In Vivo
    YEN-JU LEE, JING-GUNG CHUNG, YI-TING CHIEN, SONG-SHEI LIN and FEI-TING HSU
    Anticancer Research July 2019, 39 (7) 3669-3675; DOI: https://doi.org/10.21873/anticanres.13515
  • You have access
    Peroxiredoxin V Reduces β-Lapachone-induced Apoptosis of Colon Cancer Cells
    YUE LIU, TAEHO KWON, JI-SU KIM, NISANSALA CHANDIMALI, YING-HUA JIN, YI-XI GONG, DAN-PING XIE, YING-HAO HAN, MEI-HUA JIN, GUI-NAN SHEN, DONG KEE JEONG, DONG-SUN LEE, YU-DONG CUI and HU-NAN SUN
    Anticancer Research July 2019, 39 (7) 3677-3686; DOI: https://doi.org/10.21873/anticanres.13516
  • You have access
    Autophagy Promotes Survival of CHP-212 Neuroblastoma Cells Treated With Casiopeínas®
    ADRIANA VÁZQUEZ-AGUIRRE, ANLLELY GRIZETT GUTIÉRREZ, RAFAEL MORENO ESPARZA, ENRIQUE HERNÁNDEZ-LEMUS, LENA RUIZ-AZUARA and CARMEN MEJÍA
    Anticancer Research July 2019, 39 (7) 3687-3695; DOI: https://doi.org/10.21873/anticanres.13517
  • You have access
    The Ethanol Crude Extraction of Cyperus Rotundus Regulates Apoptosis-associated Gene Expression in HeLa Human Cervical Carcinoma Cells In Vitro
    CHIA-HSIN LIN, SHU-FEN PENG, FU-SHIN CHUEH, ZHENG-YU CHENG, CHAO-LIN KUO and JING-GUNG CHUNG
    Anticancer Research July 2019, 39 (7) 3697-3709; DOI: https://doi.org/10.21873/anticanres.13518
  • You have access
    Cisplatin and Vinorelbine -Mediated Electrochemotherapeutic Approach Against Multidrug Resistant Small Cell Lung Cancer (H69AR) In Vitro
    MAŁGORZATA DRĄG-ZALESIŃSKA, JOLANTA SACZKO, ANNA CHOROMAŃSKA, ANNA SZEWCZYK, NINA REMBIAŁKOWSKA, JULITA KULBACKA and ADAM RZECHONEK
    Anticancer Research July 2019, 39 (7) 3711-3718; DOI: https://doi.org/10.21873/anticanres.13519
  • You have access
    Interleukin-24 Transduction Modulates Human Prostate Cancer Malignancy Mediated by Regulation of Anchorage Dependence
    SHOTARO MAEHANA, YUTA MATSUMOTO, FUMIAKI KOJIMA and HIDERO KITASATO
    Anticancer Research July 2019, 39 (7) 3719-3725; DOI: https://doi.org/10.21873/anticanres.13520
  • You have access
    Combination of Vaccine Strain Measles Virus and Nimotuzumab in the Treatment of Laryngeal Cancer
    NGUYEN LINH TOAN, NGO THU HANG, NGUYEN KIM LUU, CAN VAN MAO, NGUYEN VAN BA, NGUYEN THI XUAN, TRUONG DINH CAM, NAOKI YAMAMOTO, HOANG VAN TONG and HO ANH SON
    Anticancer Research July 2019, 39 (7) 3727-3737; DOI: https://doi.org/10.21873/anticanres.13521
  • You have access
    Differential Response of BEAS-2B and H-441 Cells to Methylene Blue Photoactivation
    ROSALVA JOSEFINA RODRÍGUEZ-CÓRDOVA, CINDY ALEJANDRA GUTIÉRREZ-VALENZUELA, PASANO BOJANG, REYNALDO ESQUIVEL, PEDRO HERNÁNDEZ, KENNETH S. RAMOS, ROBERTO GUZMÁN-ZAMUDIO and ARMANDO LUCERO-ACUÑA
    Anticancer Research July 2019, 39 (7) 3739-3744; DOI: https://doi.org/10.21873/anticanres.13522
  • You have access
    Resveratrol Modulates the Redox-status and Cytotoxicity of Anticancer Drugs by Sensitizing Leukemic Lymphocytes and Protecting Normal Lymphocytes
    DONIKA IVANOVA, ZHIVKO ZHELEV, SEVERINA SEMKOVA, ICHIO AOKI and RUMIANA BAKALOVA
    Anticancer Research July 2019, 39 (7) 3745-3755; DOI: https://doi.org/10.21873/anticanres.13523
  • You have access
    Co-treatment With HIV Protease Inhibitor Nelfinavir Greatly Increases Late-phase Apoptosis of Drug-resistant KBV20C Cancer Cells Independently of P-Glycoprotein Inhibition
    JI YEONG KIM, YOO JUNG PARK, BYUNG-MU LEE and SUNGPIL YOON
    Anticancer Research July 2019, 39 (7) 3757-3765; DOI: https://doi.org/10.21873/anticanres.13524
  • You have access
    Histamine Receptor Antagonists, Loratadine and Azelastine, Sensitize P-gp-overexpressing Antimitotic Drug-resistant KBV20C Cells Through Different Molecular Mechanisms
    JI YEONG KIM, KYEONG SEOK KIM, IN SU KIM and SUNGPIL YOON
    Anticancer Research July 2019, 39 (7) 3767-3775; DOI: https://doi.org/10.21873/anticanres.13525
  • You have access
    Selenoesters and Selenoanhydrides as Novel Agents Against Resistant Breast Cancer
    ANDREA CSONKA, ANNAMÁRIA KINCSES, MÁRTA NOVÉ, ZSÓFIA VADAS, CARMEN SANMARTÍN, ENRIQUE DOMÍNGUEZ-ÁLVAREZ and GABRIELLA SPENGLER
    Anticancer Research July 2019, 39 (7) 3777-3783; DOI: https://doi.org/10.21873/anticanres.13526
  • You have access
    Tyrosine Kinase Inhibitors Imatinib and Erlotinib Increase Apoptosis of Antimitotic Drug-resistant KBV20C Cells Without Inhibiting P-gp
    JI YEONG KIM, HYUNG SIK KIM and SUNGPIL YOON
    Anticancer Research July 2019, 39 (7) 3785-3793; DOI: https://doi.org/10.21873/anticanres.13527
  • You have access
    In Vitro Evaluation of Apoptotic Induction of Butyric Acid Derivatives in Colorectal Carcinoma Cells
    LIJI PATTAYIL and HARIKUMARAN-THAMPI BALAKRISHNAN-SARASWATHI
    Anticancer Research July 2019, 39 (7) 3795-3801; DOI: https://doi.org/10.21873/anticanres.13528
  • You have access
    AXL Downstream Targeting Unravels Synergistic Drug Combinations in Ovarian Carcinoma Cells
    DESIRÈ M. ALAMPI, EMILIO CIUSANI, NIVES CARENINI, ELISABETTA CORNA, LAURA GATTI and CRISTINA CORNO
    Anticancer Research July 2019, 39 (7) 3803-3808; DOI: https://doi.org/10.21873/anticanres.13529
  • You have access
    2-Deoxy-glucose Enhances the Effect of Cisplatin and Pemetrexed in Reducing Malignant Pleural Mesothelioma Cell Proliferation But Not Spheroid Growth
    IRINI GEROGIANNI, ELEANNA PITARAKI, RAJESH M. JAGIRDAR, OLYMPIA KOULIOU, LYDIA GIANNAKOU, STEFANOS GIANNOPOULOS, ELEFTHERIOS PAPAZOGLOU, CHRISSI HATZOGLOU, KONSTANTINOS I. GOURGOULIANIS and SOTIRIOS G. ZAROGIANNIS
    Anticancer Research July 2019, 39 (7) 3809-3814; DOI: https://doi.org/10.21873/anticanres.13530
  • You have access
    In Vivo Effectiveness of Orlistat in the Suppression of Human Colorectal Cancer Cell Proliferation
    ALEKSANDRA CZUMAJ, JUDYTA ZABIELSKA, ALICJA PAKIET, ADRIANA MIKA, OLGA ROSTKOWSKA, WOJCIECH MAKAREWICZ, JAROSŁAW KOBIELA, TOMASZ SLEDZINSKI and EWA STELMANSKA
    Anticancer Research July 2019, 39 (7) 3815-3822; DOI: https://doi.org/10.21873/anticanres.13531
  • You have access
    Virtual Screening of 1,4-Naphthoquinone Derivatives for Inhibition of a Key Cancer Signaling Protein, AKT1 Kinase
    MOHD REHAN and MAGED MOSTAFA
    Anticancer Research July 2019, 39 (7) 3823-3833; DOI: https://doi.org/10.21873/anticanres.13532
  • You have access
    Lupane Triterpenoids and New Derivatives as Antiproliferative Agents Against Prostate Cancer Cells
    MARÍA JULIA CASTRO, VALERIA PILAR CAREAGA, PAULA ALEJANDRA SACCA, MARÍA BELÉN FARAONI, ANA PAULA MURRAY and JUAN CARLOS CALVO
    Anticancer Research July 2019, 39 (7) 3835-3845; DOI: https://doi.org/10.21873/anticanres.13533

Clinical Studies

  • You have access
    Marking Disappearing Colorectal Liver Metastases After Complete Response to Neoadjuvant Chemotherapy via CT – A Pilot Study
    JOVAN VUJIC, HELMUT SCHÖLLNAST, KATHARINA MARSONER, VALERIE WIENERROITHER, HEINZ BACHER, HANS-JÖRG MISCHINGER and PETER KORNPRAT
    Anticancer Research July 2019, 39 (7) 3847-3854; DOI: https://doi.org/10.21873/anticanres.13534
  • You have access
    Follow-up Results of HCV GT2 Patients After Sofosbuvir/Ribavirin Therapy: Careful Attention to Occurrence of HCC
    TOMOHIRO KANEKO, TATSUO KANDA, KAZUSHIGE NIREI, NAOKI MATSUMOTO, MOTOMI YAMAZAKI, TOSHIKATSU SHIBATA, AKINORI TAMURA, MASAHIRO OGAWA, NORIKO NAKAJIMA, SHUNICHI MATSUOKA, KAZUMICHI KURODA, TOMOE KOMORIYA, TATSUO YAMAMOTO, TADATOSHI TAKAYAMA and MITSUHIKO MORIYAMA
    Anticancer Research July 2019, 39 (7) 3855-3862; DOI: https://doi.org/10.21873/anticanres.13535
  • You have access
    Matrix-producing Carcinoma as an Aggressive Triple-negative Breast Cancer: Clinicopathological Features and Response to Neoadjuvant Chemotherapy
    KAZUHIRO SHIMADA, TAKASHI ISHIKAWA, AKIMITSU YAMADA, SADATOSHI SUGAE, KAZUTAKA NARUI, DAISUKE SHIMIZU, TAKASHI CHISHIMA and ITARU ENDO
    Anticancer Research July 2019, 39 (7) 3863-3869; DOI: https://doi.org/10.21873/anticanres.13536
  • You have access
    Clinical Characteristics Associated With Lenvatinib-induced Fistula and Tumor-related Bleeding in Patients With Thyroid Cancer
    YUKIKO STAUB, AKIHIRO NISHIYAMA, YUKIO SUGA, MIKIYA FUJITA, RYO MATSUSHITA and SEIJI YANO
    Anticancer Research July 2019, 39 (7) 3871-3878; DOI: https://doi.org/10.21873/anticanres.13537
  • You have access
    Flutamide as an Alternative Anti-androgen Agent and Predictor of the Efficacy of Novel Androgen Receptor-targeted Agents
    NORIYA YAMAGUCHI, SHUICHI MORIZANE, TETSUYA YUMIOKA, HIDETO IWAMOTO, KATSUYA HIKITA, TAKEHIRO SEJIMA, MASASHI HONDA and ATSUSHI TAKENAKA
    Anticancer Research July 2019, 39 (7) 3879-3885; DOI: https://doi.org/10.21873/anticanres.13538
  • You have access
    Initial Experience of Pembrolizumab Therapy in Japanese Patients With Metastatic Urothelial Cancer
    SHOTARO YASUOKA, TAKESHI YUASA, NORIKO NISHIMURA, MASAHIRO OGAWA, YOSHINOBU KOMAI, NOBORU NUMAO, SHINYA YAMAMOTO, YUKIHIRO KONDO and JUNJI YONESE
    Anticancer Research July 2019, 39 (7) 3887-3892; DOI: https://doi.org/10.21873/anticanres.13539
  • You have access
    Efficacy of Nilotinib in a CML Patient Expressing the Three-way Complex Variant Translocation t(2;9;22)
    ELENA TIRRÒ, MICHELE MASSIMINO, STEFANIA STELLA, VALENTINA ZAMMIT, MARIA LETIZIA CONSOLI, MARIA STELLA PENNISI, SILVIA RITA VITALE, CHIARA ROMANO, MARIA CRISTINA PIROSA, ENRICA MARTINO, SANDRA DI GREGORIO, ADRIANA PUMA, FRANSCESCO DI RAIMONDO, LIVIA MANZELLA and FABIO STAGNO
    Anticancer Research July 2019, 39 (7) 3893-3899; DOI: https://doi.org/10.21873/anticanres.13540
  • You have access
    Abiraterone Acetate and Enzalutamide: Similar Efficacy in Treating Post Docetaxel Metastatic Castration-resistant Prostate Cancer: Single Center Experience
    LI-WEN CHANG, SHENG-CHUN HUNG, SHIAN-SHIANG WANG, JIAN-RI LI, CHENG-KUANG YANG, CHUAN-SHU CHEN, HAO-CHUNG HO, CHEN-LI CHENG, YEN-CHUAN OU and KUN-YUAN CHIU
    Anticancer Research July 2019, 39 (7) 3901-3908; DOI: https://doi.org/10.21873/anticanres.13541
  • You have access
    Reduction of Intrahepatic Tumour by Hepatic Arterial Infusion Chemotherapy Prolongs Survival in Hepatocellular Carcinoma
    PIL SOO SUNG, KEUNGMO YANG, SI HYUN BAE, JUNG SUK OH, HO JONG CHUN, HEE CHUL NAM, JEONG WON JANG, JONG YOUNG CHOI and SEUNG KEW YOON
    Anticancer Research July 2019, 39 (7) 3909-3916; DOI: https://doi.org/10.21873/anticanres.13542
  • You have access
    Retreatment With Anti-PD-L1 Antibody in Advanced Non-small Cell Lung Cancer Previously Treated With Anti-PD-1 Antibodies
    KOHEI FUJITA, NAOHIRO UCHIDA, YUKI YAMAMOTO, OSAMU KANAI, MISATO OKAMURA, KOICHI NAKATANI, SATORU SAWAI and TADASHI MIO
    Anticancer Research July 2019, 39 (7) 3917-3921; DOI: https://doi.org/10.21873/anticanres.13543
  • You have access
    Which Is Better EGFR-TKI Followed by Osimertinib: Afatinib or Gefitinib/Erlotinib?
    MOTOHIRO TAMIYA, AKIHIRO TAMIYA, HIDEKAZU SUZUKI, KAZUNORI MORIIZUMI, KENJI NAKAHAMA, YOSHIHIKO TANIGUCHI, KEI KUNIMASA, MADOKA KIMURA, TAKAKO INOUE, HANAKO KUHARA, KAZUMI NISHINO, TOMONORI HIRASHIMA, SHINJI ATAGI, FUMIO IMAMURA and TORU KUMAGAI
    Anticancer Research July 2019, 39 (7) 3923-3929; DOI: https://doi.org/10.21873/anticanres.13544
  • You have access
    S-1 Monotherapy After Failure of Platinum Plus 5-Fluorouracil Chemotherapy in Recurrent or Metastatic Esophageal Carcinoma
    TAKAHIKO ITO, YOSHITAKA HONMA, HIDEKAZU HIRANO, HIROKAZU SHOJI, NATSUKO OKITA, SATORU IWASA, ATSUO TAKASHIMA, KEN KATO and NARIKAZU BOKU
    Anticancer Research July 2019, 39 (7) 3931-3936; DOI: https://doi.org/10.21873/anticanres.13545
  • You have access
    Random Allocated Study of Wrapping Oblate for Prevention of Everolimus-associated Stomatitis in Patients With Metastatic Renal Cell Carcinoma
    KWONOH PARK, YOUNGAE BAEK and JAE-LYUN LEE
    Anticancer Research July 2019, 39 (7) 3937-3944; DOI: https://doi.org/10.21873/anticanres.13546
  • You have access
    Efficacy and Toxicity of Pembrolizumab in Pediatric Metastatic Recurrent Melanoma
    AGATA MARJANSKA, PRZEMYSLAW GALAZKA, MICHAL MARJANSKI, MARIUSZ WYSOCKI and JAN STYCZYNSKI
    Anticancer Research July 2019, 39 (7) 3945-3947; DOI: https://doi.org/10.21873/anticanres.13547
  • You have access
    Efficacy of Dasatinib in a Very Elderly CML Patient Expressing a Rare E13a3 Bcr-Abl1 Fusion Transcript: A Case Report
    MICHELE MASSIMINO, STEFANIA STELLA, ELENA TIRRÒ, MARIA LETIZIA CONSOLI, MARIA STELLA PENNISI, ADRIANA PUMA, SILVIA RITA VITALE, CHIARA ROMANO, VALENTINA ZAMMIT, FABIO STAGNO, FRANCESCO DI RAIMONDO and LIVIA MANZELLA
    Anticancer Research July 2019, 39 (7) 3949-3954; DOI: https://doi.org/10.21873/anticanres.13548
  • You have access
    Panniculitis Under Successful Targeted Inhibition of the MAPK/ERK Signaling Pathway in a Patient With BRAF V600E-mutated Spindle Cell Oncocytoma of the Pituitary Gland
    LUKAS SOLLFRANK, SEBASTIAN LETTMAIER, MICHAEL ERDMANN and UGUR USLU
    Anticancer Research July 2019, 39 (7) 3955-3959; DOI: https://doi.org/10.21873/anticanres.13549
  • You have access
    Financial Toxicity and Non-small Cell Lung Cancer Treatment: The Optimization in the Choice of Immune Check Point Inhibitors
    JACOPO GIULIANI and ANDREA BONETTI
    Anticancer Research July 2019, 39 (7) 3961-3965; DOI: https://doi.org/10.21873/anticanres.13550
  • You have access
    The Onset of Grade ≥3 Neutropenia Is Associated With Longer Overall Survival in Metastatic Colorectal Cancer Patients Treated With Trifluridine/Tipiracil
    JACOPO GIULIANI and ANDREA BONETTI
    Anticancer Research July 2019, 39 (7) 3967-3969; DOI: https://doi.org/10.21873/anticanres.13551
  • You have access
    The Economic Impact of Biosimilars in Oncology and Hematology: The Case of Trastuzumab and Rituximab
    JACOPO GIULIANI and ANDREA BONETTI
    Anticancer Research July 2019, 39 (7) 3971-3973; DOI: https://doi.org/10.21873/anticanres.13552

Errata

  • You have access
    Errata
    Anticancer Research July 2019, 39 (7) 3975;
  • You have access
    Errata
    Anticancer Research July 2019, 39 (7) 3975;
  • You have access
    Errata
    Anticancer Research July 2019, 39 (7) 3975;
  • You have access
    Errata
    Anticancer Research July 2019, 39 (7) 3975;
  • You have access
    Errata
    Anticancer Research July 2019, 39 (7) 3975;

BOOK REVIEWS

  • You have access
    Book Reviews
    Anticancer Research July 2019, 39 (7) 3977;
  • You have access
    Platelets. 4th Edition
    Anticancer Research July 2019, 39 (7) 3977;
  • You have access
    Practical Guide for Biomedical Signals Analysis Using Machine Learning Techniques. 1st Edition. A MATLAB Based Approach
    Anticancer Research July 2019, 39 (7) 3977;
  • You have access
    Malignant Pleural Mesothelioma. 1st Edition. A Guide for Clinicians
    Anticancer Research July 2019, 39 (7) 3977;
  • You have access
    Reproducibility in Biomedical Research. 1st Edition. Epistemological and Statistical Problems
    Anticancer Research July 2019, 39 (7) 3977-3978;
  • You have access
    Oxford Textbook of Cancer Biology
    Anticancer Research July 2019, 39 (7) 3978;

Announcements

  • You have access
    Announcements
    Anticancer Research July 2019, 39 (7) 3979;
Back to top
PreviousNext

In this issue

Anticancer Research: 39 (7)
Anticancer Research
Vol. 39, Issue 7
July 2019
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Sign up for alerts

Jump to

  • Reviews
  • Experimental Studies
  • Clinical Studies
  • Errata
  • BOOK REVIEWS
  • Announcements
  • Top Topics
  • Most Cited
  • Most Read
Loading
Role of Resveratrol in Prevention and Therapy of Cancer: Preclinical and Clinical Studies
The Association of Solar Ultraviolet B (UVB) with Reducing Risk of Cancer: Multifactorial Ecologic Analysis of Geographic Variation in Age-adjusted Cancer Mortality Rates
Epithelial−Mesenchymal Transition in EGFR-TKI Acquired Resistant Lung Adenocarcinoma
Vitamin D Supplement Doses and Serum 25-Hydroxyvitamin D in the Range Associated with Cancer Prevention
Anticancer Research

© 2021 Anticancer Research

Powered by HighWire